Colonoscopes Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update
Summary
GlobalData's Medical Devices sector report, “Colonoscopes Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update provides comprehensive information about the Colonoscopes pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
A Colonoscope is a forward-viewing endoscope designed for examination of the entire colon and terminal ileum. A Colonoscope consists of a long and thin flexible tube having a miniature camera and light source at its distal end. The device consists of tip housing, a flexible insertion tube, and a cord that connects the light source and the tip housing. The distal part of the insertion tube is flexible enough to allow the device to travel through the angulated areas of the colon.
Note:Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
Extensive coverage of the Colonoscopes under development
The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
The report reviews the major players involved in the development of Colonoscopes and list all their pipeline projects
The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
The report provides key clinical trial data of ongoing trials specific to pipeline products
Recent developments in the segment / industry
Reasons to Buy
The report enables you to -
Formulate significant competitor information, analysis, and insights to improve R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
Identify and understand important and diverse types of Colonoscopes under development
Develop market-entry and market expansion strategies
Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
In-depth analysis of the product’s current stage of development, territory and estimated launch date
1 About GlobalData
2 Table of Contents
2.1 List of Tables
2.2 List of Figures
3 Introduction
3.1 Colonoscopes Overview
4 Products under Development
4.1 Colonoscopes - Pipeline Products by Stage of Development
4.2 Colonoscopes - Pipeline Products by Segment
4.3 Colonoscopes - Pipeline Products by Territory
4.4 Colonoscopes - Pipeline Products by Regulatory Path
4.5 Colonoscopes - Pipeline Products by Estimated Approval Date
4.6 Colonoscopes - Ongoing Clinical Trials
5 Colonoscopes - Pipeline Products under Development by Companies
5.1 Colonoscopes Companies - Pipeline Products by Stage of Development
5.2 Colonoscopes – Companies Pipeline Products by Stage of Development
7.2 Mar 04, 2024: Intelligent Scopes Launches Helga AI-GEP, an AI Platform for Gastroenterology With the Commencement of Validation of Its AI Software Tool for Colon Cancer
7.3 Feb 20, 2024: Cosmo Reports Excellent Preliminary Unaudited Full Year 2023 Core Financial Results – Record Guidance for 2024 – Doubles Dividend to € 2.00 Per Share
7.4 Jan 31, 2024: Stryker Corp Reports Strong Q4 and Full Year 2023 Results; Forecasts Continued Growth
7.5 Jan 28, 2024: Cosmo Artificial Intelligence Receives Additional 510(K) Clearance For GI Genius System
7.6 Jan 25, 2024: Cosmo Pharmaceuticals Announces Invitation to Investor Day and Full-Year 2023 Webcast - Zurich, 20 March 2024
7.7 Jan 25, 2024: New Study Shows SonarMD Drives 10X Reduction in Hospital Admissions and Emergency Visits Related to IBD
7.8 Dec 11, 2023: Medtronic and Cosmo Pharmaceuticals forge ahead in AI-driven care
7.9 Dec 06, 2023: Cosmo Confirms Full Redemption in Cash of €175m Convertible Bonds
7.1 Nov 13, 2023: Olympus Corp Announces Consolidated Financial Results for the Six Months of the Fiscal Year Ending March 31, 2024
7.11 Oct 09, 2023: Stryker to Host Investor Day
7.12 Oct 03, 2023: Olympus Names Dr. John de Csepel as Chief Medical Officer
7.13 Oct 02, 2023: Stryker to Announce Financial Results for Its Third Quarter of Fiscal Year 2023
7.14 Sep 25, 2023: Fujifilm Receives 510(k) Clearance for Endoscope Model EC-760S-A/L
Table 24: Dalin Tzu Chi General Hospital - Ongoing Clinical Trials Overview
Table 25: Real-Time Computer-Aided Colon Polyp Detection System - Adenoma Detection Using Real-Time Computer-Aided Colon Polyp Detection System to Compare Water Exchange and Air Insufflation - A Randomized Controlled Trial